Related Experiment Video
Updated: Mar 14, 2026

Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice
Published on: February 3, 2023
Increased apoptosis and browning of TAK1-deficient adipocytes protects against obesity
Antonia Sassmann-Schweda1, Pratibha Singh1, Cong Tang1
1Department of Pharmacology and.
Abstract:
Obesity is an increasing health problem worldwide, and nonsurgical strategies to treat obesity have remained rather inefficient. We here show that acute loss of TGF-β-activated kinase 1 (TAK1) in adipocytes results in an increased rate of apoptotic adipocyte death and increased numbers of M2 macrophages in white adipose tissue. Mice with adipocyte-specific TAK1 deficiency have reduced adipocyte numbers and are resistant to obesity induced by a high-fat diet or leptin deficiency. In addition, adipocyte-specific TAK1-deficient mice under a high-fat diet showed increased energy expenditure, which was accompanied by enhanced expression of the uncoupling protein UCP1. Interestingly, acute induction of adipocyte-specific TAK1 deficiency in mice already under a high-fat diet was able to stop further weight gain and improved glucose tolerance. Thus, loss of TAK1 in adipocytes reduces the total number of adipocytes, increases browning of white adipose tissue, and may be an attractive strategy to treat obesity, obesity-dependent diabetes, and other associated complications.
Insights
Losing TGF-β-activated kinase 1 (TAK1) in fat cells reduces adipocyte numbers and increases energy expenditure. This finding suggests targeting TAK1 could be a novel obesity treatment strategy.
Area of Science:
- Metabolic research
- Cell biology
- Obesity research
Background:
- Obesity is a global health crisis with limited non-surgical treatment options.
- Adipose tissue dysfunction plays a critical role in obesity and related metabolic disorders.
Purpose of the Study:
- To investigate the role of TGF-β-activated kinase 1 (TAK1) in adipocytes regarding obesity.
- To explore the therapeutic potential of targeting adipocyte TAK1 for obesity treatment.
Main Methods:
- Generated mice with adipocyte-specific TAK1 deficiency.
- Administered high-fat diets and leptin deficiency models to assess obesity resistance.
- Analyzed adipocyte apoptosis, macrophage infiltration, and energy expenditure.
Main Results:
- Loss of TAK1 in adipocytes increased adipocyte apoptosis and M2 macrophage infiltration.
- Adipocyte-specific TAK1-deficient mice exhibited reduced adipocyte numbers and resistance to diet-induced obesity.
- These mice showed increased energy expenditure, enhanced UCP1 expression, and improved glucose tolerance.
Conclusions:
- Adipocyte TAK1 deficiency reduces adipocyte count and promotes white adipose tissue browning.
- Targeting TAK1 in adipocytes presents a promising strategy for treating obesity and associated metabolic complications like diabetes.
Related Concept Videos
Apoptosis
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Extrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...

